Subacute pulmonary embolism in a hemodialysis patient, successfully treated with surgical thrombectomy

被引:1
作者
Yamasaki, Keisuke [1 ,4 ]
Haruyama, Naoki [1 ]
Taniguchi, Masatomo [1 ]
Nishida, Takahiro [2 ]
Tominaga, Ryuji [2 ]
Kitazono, Takanari [1 ]
Tsuruya, Kazuhiko [1 ,3 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Surg, Fukuoka, Japan
[3] Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan
[4] Yamaguchi Red Cross Hosp, Dept Nephrol, Yamaguchi, Japan
关键词
ADPKD; Hemodialysis; Pulmonary embolism; Tamoxifen;
D O I
10.1007/s13730-015-0195-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A 53-year-old woman was admitted to our hospital with a 1-month history of gradually progressive resting dyspnea and lumbar backache. For the preceding 6 years, she had received regular hemodialysis for end-stage renal disease caused by autosomal dominant polycystic kidney disease and had taken tamoxifen for 3 years as post-operative chemotherapy for breast cancer. Before admission, the patient's symptoms had been attributed to volume overload, based on right thoracic fluid and leg edema. However, despite volume correction by dialysis therapy, her symptoms had not improved. The patient was transferred to our hospital, where she was diagnosed with subacute pulmonary embolism (PE). Emergent pulmonary thrombectomy was performed using cardio-pulmonary bypass. The patient was discharged from our hospital on post-operative day 23. Recent reports have shown that hemodialysis patients have a relatively higher risk of PE compared with the general population. Our case had additional risk factors for PE: female sex, decreased protein C level, tamoxifen use, and autosomal dominant polycystic kidney disease. These factors may have had a synergistic effect on the onset of PE.
引用
收藏
页码:74 / 77
页数:4
相关论文
共 18 条
[1]  
Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0
[2]   Risk of ischemic stroke with tamoxifen treatment for breast cancer - A meta-analysis [J].
Bushnell, CD ;
Goldstein, LB .
NEUROLOGY, 2004, 63 (07) :1230-1233
[3]   Thrombosis in end-stage renal disease [J].
Casserly, LF ;
Dember, LM .
SEMINARS IN DIALYSIS, 2003, 16 (03) :245-256
[4]   Ascites in a polycystic patient [J].
Chauveau, D ;
Grunfeld, JP ;
Durand, F ;
Belghiti, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (01) :228-230
[5]   Tamoxifen Treatment and Risk of Deep Venous Thrombosis and Pulmonary Embolism [J].
Hernandez, Rohini K. ;
Sorensen, Henrik Toft ;
Pedersen, Lars ;
Jacobsen, Jacob ;
Lash, Timothy L. .
CANCER, 2009, 115 (19) :4442-4449
[6]   Outcomes of renal transplantation in patients with autosomal dominant polycystic kidney disease: a nationwide longitudinal study [J].
Jacquet, Antoine ;
Pallet, Nicolas ;
Kessler, Michele ;
Hourmant, Maryvonne ;
Garrigue, Valerie ;
Rostaing, Lionel ;
Kreis, Henri ;
Legendre, Christophe ;
Mamzer-Bruneel, Marie-France .
TRANSPLANT INTERNATIONAL, 2011, 24 (06) :582-587
[7]   Pulmonary Embolism in Patients with CKD and ESRD [J].
Kumar, Gagan ;
Sakhuja, Ankit ;
Taneja, Amit ;
Majumdar, Tilottama ;
Patel, Jayshil ;
Whittle, Jeff ;
Nanchal, Rahul .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (10) :1584-1590
[8]  
Maruyama Yuji, 2006, Ann Thorac Cardiovasc Surg, V12, P60
[9]  
Mohan B, 2013, WORLD J CARDIOL, V5, P141, DOI 10.4330/wjc.v5.i5.141
[10]   Coagulation disorders in uremia [J].
Molino, D ;
De Lucia, D ;
De Santo, NG .
SEMINARS IN NEPHROLOGY, 2006, 26 (01) :46-51